Commentary: Pharm Biotechnol Curr Res (1-2)
Alzheimer Disease is a Neurological Condition that Causes Dementia
Author(s): Nicole Li
DOI: 10.36648/ippbcr.7.1.141
Commentary: Pharm Biotechnol Curr Res (1-2)
Development of Pharmaceutical Products and Drug Delivery
Author(s): Zhen Luo
DOI: 10.36648/ippbcr.7.1.142
Perspective Article: Pharm Biotechnol Curr Res (1-2)
Primary Drawbacks of the Current Cancer Chemotherapeutics
Author(s): Celebioglu Shah
DOI: 10.36648/ippbcr.7.1.142
Perspective Article: Pharm Biotechnol Curr Res (1-2)
The Drug Development Process Adoption of the Quality by Design
Author(s): Mingshi Zmaily
DOI: 10.36648/ippbcr.7.1.142
Opinion Article: Pharm Biotechnol Curr Res (1-2)
Applications of Nanotechnology for the Effective Delivery of Drugs
Author(s): Ebrahimzadeh Pingye
DOI: 10.36648/2576-1412.7.1.144
Commentary: Pharm Biotechnol Curr Res (1-2)
Combining the Capabilities of an Artificial Neural Network
Author(s): Rangan Gup
Commentary: Pharm Biotechnol Curr Res (1-2)
The Recommended Prophylaxis For Infants Born To Mothers With Chronic Hepatitis B Virus
Author(s): Jacobus Boviatsis
DOI: 10.36648/ippbcr.7.1.147
Perspective Article: Pharm Biotechnol Curr Res (1-2)
Hepatitis B Infection Necessitates Universal Vaccination at Birth and During Infancy
Author(s): Giner L
DOI: 10.36648/ippbcr.7.1.148
Perspective Article: Pharm Biotechnol Curr Res (1-2)
This Hepatitis B alongside Hepatitis C Can Cause Hepatocellular Carcinoma
Author(s): Boviatsis Elie
DOI: 10.36648/ippbcr.7.1.149
Opinion Article: Pharm Biotechnol Curr Res (1-2)
Demonstrates That Plasma Metabolites Can Be Measured To Identify Early HCC
Author(s): Popper Karl
DOI: 10.36648/ippbcr.7.1.150
Pharmaceutical Biotechnology: Current Research received 45 citations as per Google Scholar report